(Q48922793)

16 February 2018

title

Comparison of the continuous performance test with and without working memory demands in healthy controls and patients with schizophrenia. (English)

1 reference

16 February 2018

0 references

0 references

M M Kurtz

1

1 reference

16 February 2018

J D Ragland

2

1 reference

16 February 2018

W Bilker

3

1 reference

16 February 2018

R C Gur

4

1 reference

16 February 2018

R E Gur

5

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

16 February 2018

number of pages

10

1 reference

inferred from page(s)

published in

Schizophrenia Research

1 reference

16 February 2018

volume

48

1 reference

16 February 2018

page(s)

307-316

1 reference

16 February 2018

issue

2-3

1 reference

16 February 2018

Visual attention and symptoms in schizophrenia: a 1-year follow-up

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Elementary phenotypes in the neurobiological and genetic study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Scale for the assessment of thought, language, and communication (TLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

1 reference

7 January 2021

The neuropsychological signature of schizophrenia: generalized or differential deficit?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Attentional impairments in deficit and nondeficit forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Impaired attention, genetics, and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Positive and negative schizophrenic symptoms, attention, and information processing

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Construct validity in psychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Impact of neuroleptic medications on continuous performance test measures in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Working memory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Relations among clinical scales in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Clinical symptom dimensions and deficits on the Continuous Performance Test in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Attentional vulnerability indicators, thought disorder, and negative symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Attention Dysfunction in Chronic Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

The effects of daily administration of carphenazine on attention in the schizophrenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Sustained attention and positive formal thought disorder in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Matching for education in studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

A continuous performance test of brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Medication may be required for the development of automatic information processing in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Volunteers for biomedical research. Recruitment and screening of normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Phenomenology and functioning in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Relations between attentional deficits and clinical symptoms in schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

An attentional assessment of foster children at risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2800%2900060-8

7 January 2021

10.1016/S0920-9964(00)00060-8

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

11295383

1 reference

16 February 2018